Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-12

FDA Approved: FINGOLIMOD — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approved a supplemental application for Fingolimod from Quallent Pharmaceuticals Health LLC under an ANDA, updating the approved fingolimod product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD)